• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于聚天冬氨酸的聚合物纳米颗粒用于局部和全身 mRNA 递送。

Poly(aspartic acid)-Based Polymeric Nanoparticle for Local and Systemic mRNA Delivery.

机构信息

Department of Pharmaceutical Sciences, College of Pharmacy, Oregon State University, Portland, Oregon 97239, United States.

出版信息

Mol Pharm. 2022 Dec 5;19(12):4696-4704. doi: 10.1021/acs.molpharmaceut.2c00738. Epub 2022 Nov 21.

DOI:10.1021/acs.molpharmaceut.2c00738
PMID:36409995
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9826779/
Abstract

Recently, therapeutics based on mRNA (mRNA) have attracted significant interest for vaccines, cancer immunotherapy, and gene editing. However, the lack of biocompatible vehicles capable of delivering mRNA to the target tissue and efficiently expressing the encoded proteins impedes the development of mRNA-based therapies for a variety of diseases. Herein, we report mRNA-loaded polymeric nanoparticles based on diethylenetriamine-substituted poly(aspartic acid) that induce protein expression in the lungs and muscles following intravenous and intramuscular injections, respectively. Animal studies revealed that the amount of polyethylene glycol (PEG) on the nanoparticle surface affects the translation of the delivered mRNA into the encoded protein in the target tissue. After systemic administration, only mRNA-loaded nanoparticles modified with PEG at a molar ratio of 1:1 (PEG/polymer) induce protein expression in the lungs. In contrast, protein expression was detected only following intramuscular injection of mRNA-loaded nanoparticles with a PEG/polymer ratio of 10:1. These findings suggest that the PEG density on the surface of poly(aspartic acid)-based nanoparticles should be optimized for different delivery routes depending on the purpose of the mRNA treatment.

摘要

最近,基于信使 RNA(mRNA)的治疗方法在疫苗、癌症免疫疗法和基因编辑方面引起了极大的关注。然而,缺乏能够将 mRNA 递送到靶组织并有效表达编码蛋白的生物相容性载体,阻碍了基于 mRNA 的治疗方法在各种疾病中的发展。在此,我们报告了基于二亚乙基三胺取代聚(天冬氨酸)的负载 mRNA 的聚合物纳米粒子,它们分别通过静脉内和肌肉内注射在肺部和肌肉中诱导蛋白表达。动物研究表明,纳米粒子表面上的聚乙二醇(PEG)的量会影响递送到靶组织中的编码蛋白的 mRNA 的翻译。在系统给药后,只有用摩尔比为 1:1(PEG/聚合物)修饰的负载 mRNA 的纳米粒子在肺部诱导蛋白表达。相比之下,仅在肌肉内注射 PEG/聚合物比为 10:1 的负载 mRNA 的纳米粒子后才检测到蛋白表达。这些发现表明,基于聚(天冬氨酸)的纳米粒子表面上的 PEG 密度应根据 mRNA 治疗的目的针对不同的给药途径进行优化。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c6a/9826779/445a53524202/nihms-1862435-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c6a/9826779/9a97054f6ed4/nihms-1862435-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c6a/9826779/a89a58c83f6f/nihms-1862435-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c6a/9826779/e61ded84225c/nihms-1862435-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c6a/9826779/bbb7016f1b9b/nihms-1862435-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c6a/9826779/4c674400df31/nihms-1862435-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c6a/9826779/445a53524202/nihms-1862435-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c6a/9826779/9a97054f6ed4/nihms-1862435-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c6a/9826779/a89a58c83f6f/nihms-1862435-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c6a/9826779/e61ded84225c/nihms-1862435-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c6a/9826779/bbb7016f1b9b/nihms-1862435-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c6a/9826779/4c674400df31/nihms-1862435-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c6a/9826779/445a53524202/nihms-1862435-f0007.jpg

相似文献

1
Poly(aspartic acid)-Based Polymeric Nanoparticle for Local and Systemic mRNA Delivery.基于聚天冬氨酸的聚合物纳米颗粒用于局部和全身 mRNA 递送。
Mol Pharm. 2022 Dec 5;19(12):4696-4704. doi: 10.1021/acs.molpharmaceut.2c00738. Epub 2022 Nov 21.
2
Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review.脂质-聚合物杂化纳米颗粒作为新一代治疗性递送平台:综述
Eur J Pharm Biopharm. 2013 Nov;85(3 Pt A):427-43. doi: 10.1016/j.ejpb.2013.07.002. Epub 2013 Jul 17.
3
A poly(amidoamine)-based polymeric nanoparticle platform for efficient in vivo delivery of mRNA.一种基于聚酰胺-胺的聚合物纳米颗粒平台,用于高效体内递送 mRNA。
Biomater Adv. 2024 Jan;156:213713. doi: 10.1016/j.bioadv.2023.213713. Epub 2023 Nov 30.
4
Optimization of a Degradable Polymer-Lipid Nanoparticle for Potent Systemic Delivery of mRNA to the Lung Endothelium and Immune Cells.优化一种可降解聚合物-脂质纳米颗粒,以实现 mRNA 对肺内皮细胞和免疫细胞的高效系统递释。
Nano Lett. 2018 Oct 10;18(10):6449-6454. doi: 10.1021/acs.nanolett.8b02917. Epub 2018 Sep 20.
5
Polymer-Lipid Nanoparticles for Systemic Delivery of mRNA to the Lungs.聚合物-脂质纳米颗粒用于将 mRNA 全身递送至肺部。
Angew Chem Int Ed Engl. 2016 Oct 24;55(44):13808-13812. doi: 10.1002/anie.201608450. Epub 2016 Sep 30.
6
PEGylation of poly(amine-co-ester) polyplexes for tunable gene delivery.聚(胺-酯)共聚物的聚乙二醇化用于基因传递的可调控制。
Biomaterials. 2021 May;272:120780. doi: 10.1016/j.biomaterials.2021.120780. Epub 2021 Mar 24.
7
Synthesis and application of poly(ethylene glycol)-co-poly(β-amino ester) copolymers for small cell lung cancer gene therapy.用于小细胞肺癌基因治疗的聚(乙二醇)-共-聚(β-氨基酯)共聚物的合成与应用
Acta Biomater. 2016 Sep 1;41:293-301. doi: 10.1016/j.actbio.2016.05.040. Epub 2016 Jun 1.
8
5-Fluorouracil-loaded PLA/PLGA PEG-PPG-PEG polymeric nanoparticles: formulation, in vitro characterization and cell culture studies.载 5-氟尿嘧啶的 PLA/PLGA-PEG-PPG-PEG 嵌段共聚物纳米粒的制备、体外评价及细胞培养研究。
Drug Dev Ind Pharm. 2014 Apr;40(4):560-7. doi: 10.3109/03639045.2013.775581. Epub 2013 Apr 18.
9
Smart polymeric nanoparticles with pH-responsive and PEG-detachable properties for co-delivering paclitaxel and survivin siRNA to enhance antitumor outcomes.具有 pH 响应和聚乙二醇可分离特性的智能聚合物纳米粒,用于共递送紫杉醇和生存素 siRNA 以增强抗肿瘤效果。
Int J Nanomedicine. 2018 Apr 20;13:2405-2426. doi: 10.2147/IJN.S161426. eCollection 2018.
10
Impact of PEGylation on an antibody-loaded nanoparticle-based drug delivery system for the treatment of inflammatory bowel disease.聚乙二醇化对用于治疗炎症性肠病的载抗体纳米颗粒药物传递系统的影响。
Acta Biomater. 2022 Mar 1;140:561-572. doi: 10.1016/j.actbio.2021.12.015. Epub 2021 Dec 16.

引用本文的文献

1
Controlled Release of Poly(U) via Acetalated Dextran Microparticles for Enhanced Vaccine Adjuvant Delivery.通过乙酰化葡聚糖微粒实现聚脲的控释以增强疫苗佐剂递送
bioRxiv. 2025 Jul 21:2025.07.16.665134. doi: 10.1101/2025.07.16.665134.
2
Strategic Advances in Targeted Delivery Carriers for Therapeutic Cancer Vaccines.治疗性癌症疫苗靶向递送载体的战略进展
Int J Mol Sci. 2025 Jul 17;26(14):6879. doi: 10.3390/ijms26146879.
3
Mannose/stearyl chloride doubly functionalized polyethylenimine as a nucleic acid vaccine carrier to promote macrophage uptake.

本文引用的文献

1
mRNA-based therapeutics: powerful and versatile tools to combat diseases.mRNA 疗法:抗击疾病的强大而多功能的工具。
Signal Transduct Target Ther. 2022 May 21;7(1):166. doi: 10.1038/s41392-022-01007-w.
2
The clinical progress of mRNA vaccines and immunotherapies.mRNA 疫苗和免疫疗法的临床进展。
Nat Biotechnol. 2022 Jun;40(6):840-854. doi: 10.1038/s41587-022-01294-2. Epub 2022 May 9.
3
The replacement of helper lipids with charged alternatives in lipid nanoparticles facilitates targeted mRNA delivery to the spleen and lungs.
甘露糖/硬脂酰氯双官能化聚乙烯亚胺作为核酸疫苗载体促进巨噬细胞摄取。
Drug Deliv. 2024 Dec;31(1):2427138. doi: 10.1080/10717544.2024.2427138. Epub 2024 Nov 14.
4
Advancements and challenges in mRNA and ribonucleoprotein-based therapies: From delivery systems to clinical applications.基于mRNA和核糖核蛋白的疗法的进展与挑战:从递送系统到临床应用
Mol Ther Nucleic Acids. 2024 Aug 19;35(3):102313. doi: 10.1016/j.omtn.2024.102313. eCollection 2024 Sep 10.
5
Virus-like structures for combination antigen protein mRNA vaccination.用于组合抗原蛋白 mRNA 疫苗接种的病毒样结构。
Nat Nanotechnol. 2024 Aug;19(8):1224-1233. doi: 10.1038/s41565-024-01679-1. Epub 2024 May 27.
6
Recent Progress in Nucleic Acid Pulmonary Delivery toward Overcoming Physiological Barriers and Improving Transfection Efficiency.核酸肺部递呈技术克服生理屏障并提高转染效率的最新进展。
Adv Sci (Weinh). 2024 May;11(18):e2309748. doi: 10.1002/advs.202309748. Epub 2024 Mar 9.
7
mRNA Delivery: Challenges and Advances through Polymeric Soft Nanoparticles.mRNA 递送:通过聚合物软纳米颗粒的挑战与进展。
Int J Mol Sci. 2024 Feb 1;25(3):1739. doi: 10.3390/ijms25031739.
8
mRNA nanodelivery systems: targeting strategies and administration routes.信使核糖核酸纳米递送系统:靶向策略与给药途径
Biomater Res. 2023 Sep 22;27(1):90. doi: 10.1186/s40824-023-00425-3.
在脂质纳米粒中用带电替代物替代辅助脂质,可促进靶向 mRNA 递送至脾脏和肺部。
J Control Release. 2022 May;345:819-831. doi: 10.1016/j.jconrel.2022.03.046. Epub 2022 Mar 26.
4
Opportunities and Challenges for mRNA Delivery Nanoplatforms.mRNA 递送纳米平台的机遇与挑战。
J Phys Chem Lett. 2022 Feb 10;13(5):1314-1322. doi: 10.1021/acs.jpclett.1c03898. Epub 2022 Feb 2.
5
On the mechanism of tissue-specific mRNA delivery by selective organ targeting nanoparticles.选择性靶向器官纳米颗粒介导组织特异性 mRNA 递送的机制研究。
Proc Natl Acad Sci U S A. 2021 Dec 28;118(52). doi: 10.1073/pnas.2109256118.
6
The role of nanoparticle format and route of administration on self-amplifying mRNA vaccine potency.纳米颗粒形式和给药途径对自扩增 mRNA 疫苗效力的影响。
J Control Release. 2022 Feb;342:388-399. doi: 10.1016/j.jconrel.2021.12.008. Epub 2021 Dec 10.
7
Non-liver mRNA Delivery.非肝脏信使核糖核酸递送
Acc Chem Res. 2022 Jan 4;55(1):13-23. doi: 10.1021/acs.accounts.1c00601. Epub 2021 Dec 3.
8
mRNA vaccines for infectious diseases: principles, delivery and clinical translation.传染病的 mRNA 疫苗:原理、传递和临床转化。
Nat Rev Drug Discov. 2021 Nov;20(11):817-838. doi: 10.1038/s41573-021-00283-5. Epub 2021 Aug 25.
9
Advances in mRNA non-viral delivery approaches.信使核糖核酸非病毒递送方法的进展
Adv Drug Deliv Rev. 2021 Oct;177:113930. doi: 10.1016/j.addr.2021.113930. Epub 2021 Aug 14.
10
Ionization and structural properties of mRNA lipid nanoparticles influence expression in intramuscular and intravascular administration.mRNA 脂质纳米粒的离子化和结构特性影响其在肌内和血管内给药中的表达。
Commun Biol. 2021 Aug 11;4(1):956. doi: 10.1038/s42003-021-02441-2.